Jane Street
RCKT icon

Jane Street’s Rocket Pharmaceuticals RCKT Stock Holding History

Jane Street’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1K Buy
+12,600
New +$50.1K ﹤0.01% 11009
2025
Q4 		– Sell
-45,700
Closed -$149K – 12147
2025
Q3 		$149K Buy
45,700
+5,400
+13% +$17K ﹤0.01% 9884
2025
Q2 		$98.7K Buy
+40,300
New +$204K ﹤0.01% 8953
2024
Q4 		– Sell
-10,200
Closed -$188K – 10359
2024
Q3 		$188K Sell
10,200
-3,300
-24% -$67.6K ﹤0.01% 8687
2024
Q2 		$291K Buy
13,500
+1,700
+14% +$39K ﹤0.01% 7852
2024
Q1 		$318K Sell
11,800
-209,200
-95% -$5.94M ﹤0.01% 7467
2023
Q4 		$6.62M Sell
221,000
-29,300
-12% -$647K ﹤0.01% 2464
2023
Q3 		$5.13M Buy
+250,300
New +$4.55M ﹤0.01% 2571
2022
Q4 		– Sell
-19,300
Closed -$308K – 9960
2022
Q3 		$308K Buy
19,300
+500
+3% +$7.8K ﹤0.01% 7545
2022
Q2 		$259K Buy
+18,800
New +$224K ﹤0.01% 7828
2021
Q2 		– Sell
-7,600
Closed -$337K – 10297
2021
Q1 		$337K Sell
7,600
-5,600
-42% -$307K ﹤0.01% 7512
2020
Q4 		$724K Buy
+13,200
New +$481K ﹤0.01% 5169

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street's RCKT Position: Q1 2026 in Review

Jane Street increased its Rocket Pharmaceuticals (RCKT) stake by 3.4% in Q1 2026, buying an estimated $82.6K and bringing the position to 623,354 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4873.

Jane Street first reported a position in RCKT in Q3 2020 and has held it in 21 quarters since. The position peaked at $3.28M in Q3 2024. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Jane Street held 623,354 shares of Rocket Pharmaceuticals worth $2.23M as of Q1 2026.
  • Jane Street bought 20,774 Rocket Pharmaceuticals shares in Q1 2026, an estimated $82.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4873 holding.
  • Jane Street first reported a position in Rocket Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • Jane Street's Rocket Pharmaceuticals position peaked at $3.28M in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.